Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 404187

Known as: LY-404187, LY404187 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
RationaleDrugs that enhance α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor-mediated glutamatergic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2004
Review
2004
Glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors mediate most of the excitatory… Expand
Highly Cited
2004
Highly Cited
2004
Recent developments in the molecular biology and pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA… Expand
2004
2004
AMPA receptor potentiators enhance AMPA receptor-mediated glutamatergic neurotransmission and may have therapeutic potential as… Expand
Highly Cited
2003
Highly Cited
2003
Four positive modulators of AMPA-type glutamate receptors (cyclothiazide, CX614, LY404187 and S18986-1) given in acute or chronic… Expand
Highly Cited
2002
Highly Cited
2002
AMPA receptor activation has been demonstrated to increase the neuronal expression of brain derived neurotrophic factor (BDNF… Expand
Review
2002
Review
2002
LY404187 is a selective, potent and centrally active positive allosteric modulator of AMPA receptors. LY404187 preferentially… Expand
Highly Cited
2001
Highly Cited
2001
The present study describes the activity of two novel potent and selective AMPA receptor potentiator molecules LY392098 and… Expand
2001
2001
The present study describes the pharmacological activity of two novel positive allosteric modulators at AMPA receptors in acutely… Expand
2001
2001
Positive modulators of glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors can enhance cognitive… Expand